Ocular Therapeutix annual shares outstanding
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Ocular Therapeutix Shares Outstanding History (OCUL)
Ocular Therapeutix reported 215.9M shares outstanding at the end of fiscal 2025.
View full Ocular Therapeutix company overviewOcular Therapeutix annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 215.9M | 58.2M | +36.88% |
| 2024 | 2024-12-31 | 157.7M | 42.8M | +37.22% |
| 2023 | 2023-12-31 | 115.0M | 37.8M | +48.91% |
| 2022 | 2022-12-31 | 77.2M | 469,879 | +0.61% |
| 2021 | 2021-12-31 | 76.7M | 735,208 | +0.97% |
| 2020 | 2020-12-31 | 76.0M | 25.7M | +50.99% |
| 2019 | 2019-12-31 | 50.3M | 8.8M | +21.23% |
| 2018 | 2018-12-31 | 41.5M | 11.9M | +39.99% |
| 2017 | 2017-12-31 | 29.7M | 4.6M | +18.52% |
| 2016 | 2016-12-31 | 25.0M | 273,819 | +1.11% |
| 2015 | 2015-12-31 | 24.8M | 3.4M | +16.02% |
| 2014 | 2014-12-31 | 21.3M | 18.7M | +697.02% |
| 2013 | 2013-12-31 | 2.7M | — | — |
Ocular Therapeutix quarterly shares outstanding
Q4.13
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 219.6M | 46.7M | +26.98% |
| Q1 2026 | 2026-03-31 | 218.9M | 59.6M | +37.44% |
| Q4 2025 | 2025-12-31 | 215.9M | 58.2M | +36.88% |
| Q3 2025 | 2025-09-30 | 174.9M | 18.3M | +11.68% |
| Q2 2025 | 2025-06-30 | 172.9M | 17.3M | +11.12% |
| Q1 2025 | 2025-03-31 | 159.3M | 4.6M | +2.95% |
| Q4 2024 | 2024-12-31 | 157.7M | 42.8M | +37.22% |
| Q3 2024 | 2024-09-30 | 156.7M | 77.2M | +97.27% |
| Q2 2024 | 2024-06-30 | 155.6M | 76.4M | +96.41% |
| Q1 2024 | 2024-03-31 | 154.7M | 77.2M | +99.58% |
| Q4 2023 | 2023-12-31 | 115.0M | 37.8M | +48.91% |
| Q3 2023 | 2023-09-30 | 79.4M | 2.4M | +3.12% |
| Q2 2023 | 2023-06-30 | 79.2M | 2.3M | +3.02% |
| Q1 2023 | 2023-03-31 | 77.5M | 757,024 | +0.99% |
| Q4 2022 | 2022-12-31 | 77.2M | 469,879 | +0.61% |
| Q3 2022 | 2022-09-30 | 77.0M | 403,417 | +0.53% |
| Q2 2022 | 2022-06-30 | 76.9M | 455,429 | +0.60% |
| Q1 2022 | 2022-03-31 | 76.8M | 522,904 | +0.69% |
| Q4 2021 | 2021-12-31 | 76.7M | 735,208 | +0.97% |
| Q3 2021 | 2021-09-30 | 76.6M | 13.5M | +21.46% |
| Q2 2021 | 2021-06-30 | 76.5M | 13.5M | +21.45% |
| Q1 2021 | 2021-03-31 | 76.2M | 23.2M | +43.74% |
| Q4 2020 | 2020-12-31 | 76.0M | 25.7M | +50.99% |
| Q3 2020 | 2020-09-30 | 63.1M | 15.0M | +31.18% |
| Q2 2020 | 2020-06-30 | 63.0M | 18.9M | +42.75% |
| Q1 2020 | 2020-03-31 | 53.0M | 10.2M | +23.81% |
| Q4 2019 | 2019-12-31 | 50.3M | 8.8M | +21.23% |
| Q3 2019 | 2019-09-30 | 48.1M | 7.6M | +18.64% |
| Q2 2019 | 2019-06-30 | 44.1M | 5.6M | +14.62% |
| Q1 2019 | 2019-03-31 | 42.8M | 5.6M | +14.91% |
| Q4 2018 | 2018-12-31 | 41.5M | 11.9M | +39.99% |
| Q3 2018 | 2018-09-30 | 40.5M | 11.1M | +37.89% |
| Q2 2018 | 2018-06-30 | 38.5M | 9.4M | +32.43% |
| Q1 2018 | 2018-03-31 | 37.3M | 8.3M | +28.84% |
| Q4 2017 | 2017-12-31 | 29.7M | 4.6M | +18.52% |
| Q3 2017 | 2017-09-30 | 29.4M | 4.5M | +18.12% |
| Q2 2017 | 2017-06-30 | 29.1M | 4.2M | +17.06% |
| Q1 2017 | 2017-03-31 | 28.9M | 4.2M | +16.87% |
| Q4 2016 | 2016-12-31 | 25.0M | 273,819 | +1.11% |
| Q3 2016 | 2016-09-30 | 24.9M | 149,826 | +0.61% |
| Q2 2016 | 2016-06-30 | 24.8M | 102,305 | +0.41% |
| Q1 2016 | 2016-03-31 | 24.8M | 3.3M | +15.54% |
| Q4 2015 | 2015-12-31 | 24.8M | 3.4M | +16.02% |
| Q3 2015 | 2015-09-30 | 24.7M | 3.4M | +15.98% |
| Q2 2015 | 2015-06-30 | 24.7M | 23.5M | +1989.77% |
| Q1 2015 | 2015-03-31 | 21.4M | 18.8M | +700.57% |
| Q4 2014 | 2014-12-31 | 21.3M | — | — |
| Q3 2014 | 2014-09-30 | 21.3M | — | — |
| Q2 2014 | 2014-06-30 | 1.2M | — | — |
| Q4 2013 | 2013-12-31 | 2.7M | — | — |
Ocular Therapeutix shares outstanding trends
Over the last five reported fiscal years, Ocular Therapeutix's shares outstanding moved from 76.0M to 215.9M, a change of 139.9M. The latest reported quarter, Q2 2026, shows 219.6M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ocular Therapeutix filings at SEC.gov ↗